Drug Trial Radar · NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
751
Planned (sponsor's estimate)
Start
Jan 16, 2026
Primary completion
Sep 21, 2028
Study completion Apr 28, 2033
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- Collaborators
- Teva Branded Pharmaceutical Products R&D LLC
- First posted
- Sep 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 286 weeks including: * 40-week Pivotal Maintenance Sub-Study * 240-week Open-Label Extension (OLE) Sub-Study * 45-day Follow-up Visit Note: For the participants who do not enroll into OLE Sub-Study, the duration will be up to 46 weeks, including the 40-week maintenance period and a 45-day follow-up visit. The treatment duration may be up to 280 weeks including: * 40 weeks in Pivotal Maintenance Sub-Study * 240 weeks in OLE Sub-Study The total number of on-site visit will be up to 32: * 21 visits in the Pivotal Maintenance Sub-Study. * 11 visits in the OLE Sub-Study.
Conditions
- Ulcerative Colitis
Interventions
DuvakitugDrug
Pharmaceutical form: Injection solution Route of administration: SC injection
PlaceboDrug
Pharmaceutical form:Injection solution-Route of administration:SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants achieving clinical remission by modified Mayo Score (mMS).Time frame: Week 40
Locations
171 sites in 31 countries. Site status is shown where the registry gives one.
Del Sol Research Management, LLC - Site Number: 8400012
Tucson, Arizona · Recruiting
Southern California GI & Liver Centers - Site Number: 8400062
Coronado, California · Recruiting
United Medical Doctors CA - Site Number: 8400044
Murrieta, California · Recruiting
Om Research, LLC - Victorville - Site Number: 8400022
Victorville, California · Recruiting
Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039
Colorado Springs, Colorado · Recruiting
Clinical Research of Osceola - Site Number: 8400013
Kissimmee, Florida · Recruiting
Bioresearch Partner-Kendale Lakes - Site Number: 8400053
Miami, Florida · Recruiting
NMC Research LLC - Site Number: 8400033
Tampa, Florida · Recruiting
Atlanta Gastroenterology Associates-Site Number: 8400109
Atlanta, Georgia · Recruiting
Grand Teton Research Group, PLLC-Site Number: 8400127
Idaho Falls, Idaho · Recruiting
GI Alliance - Gurnee-Site Number:
Gurnee, Illinois · Recruiting
Gastroenterology Health Partners, PLLC - New Albany - Site Number: 8400100
New Albany, Indiana · Recruiting
University of Kentucky Hospital/UK Albert B. Chandler Hospital-Site Number: 8400058
Lexington, Kentucky · Recruiting
GI Alliance - Baton Rouge - Site Number: 8400129
Baton Rouge, Louisiana · Recruiting
Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville - Site Number: 8400128
Mandeville, Louisiana · Recruiting
Delta Research Partners - Site Number: 8400087
Monroe, Louisiana · Recruiting
UMass Memorial Medical Center-Site Number: 8400121
Worcester, Massachusetts · Recruiting
Gastroenterology Associates of Western Michigan - Site Number: 8400060
Wyoming, Michigan · Recruiting
Gateway Gastroenterology - Site Number: 8400097
Chesterfield, Missouri · Recruiting
BVL Clinical Research - Site Number: 8400005
Liberty, Missouri · Recruiting
Premier Health Research, LLC-Site Number: 8400114
Sparta, New Jersey · Recruiting
MedTraits NY - Site Number: 8400045
Maspeth, New York · Recruiting
NYU Langone Health-Site Number: 8400091
New York, New York · Recruiting
Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040
New York, New York · Recruiting
Lenox Hill Hospital-Site Number: 8400052
New York, New York · Recruiting
New York Gastroenterology Associates - Site Number: 8400009
New York, New York · Recruiting
Cross Creek Medical Clinic - Site Number: 8400057
Fayetteville, North Carolina · Recruiting
Ohio Gastroenterology Group Inc. - Site Number: 8400006
Columbus, Ohio · Recruiting
North Shore Gastroenterology Research - Site Number: 8400130
Westlake, Ohio · Recruiting
The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107
Pittsburgh, Pennsylvania · Recruiting
University Gastroenterology-Site Number: 8400103
Providence, Rhode Island · Recruiting
One of a Kind Clinical Research Center TX, LLC-Site Number: 8400125
Kingwood, Texas · Recruiting
GI Alliance - Lubbock - Site Number: 8400092
Lubbock, Texas · Recruiting
Gastroenterology Research of San Antonio LLC - Site Number: 8400054
San Antonio, Texas · Recruiting
Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101
Southlake, Texas · Recruiting
Tyler Research Institute, LLC - Site Number: 8400095
Tyler, Texas · Recruiting
The Vancouver Clinic Inc. P.S. - Site Number: 8400090
Vancouver, Washington · Recruiting
Investigational Site Number : 0320007
Rosario, Santa Fe Province, Argentina · Recruiting
Investigational Site Number : 0360001
South Brisbane, Australia · Recruiting
Investigational Site Number : 0400002
Salzburg, Austria · Recruiting
Showing 40 of 171 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.